IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Proqr Thrapeutics N V

CUSIP: N71542959 | 3 institutional holders

Quarters

Q3 2026Q2 2025Q1 2025Q4 2024Q3 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile